{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Thymopentin",
  "nciThesaurus": {
    "casRegistry": "69558-55-0",
    "chebiId": "",
    "chemicalFormula": "C30H49N9O9",
    "definition": "A synthetic pentapeptide which is the active site of the naturally occurring hormone thymopoietin with immunomodulating properties. Thymopentin enhances the production of thymic T cells and may help restore immunocompetence in immunosuppressed subjects. This agent also augments the effects of ionizing radiation by arresting cancer cells in the G2/M phase of the cell cycle.",
    "fdaUniiCode": "O3Y80ZF13F",
    "identifier": "C1294",
    "preferredName": "Thymopentin",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C2139"
    ],
    "synonyms": [
      "Immunox",
      "Mepentil",
      "N-(N-(N-(N(2)-L-Arginyl-L-Lysyl)-L-alpha-Aspartyl)-L-Valyl)-L-Tyrosine",
      "N-[N-[N-(N{2}-L-Arginyl-L-lysyl)-L-alpha-aspartyl]-L-valyl]-L-tyrosine",
      "ORF-15244",
      "Sintomodulina",
      "THYMOPENTIN",
      "Thymopentin",
      "Timunox"
    ]
  }
}